(Q41635862)

5 October 2017

1 reference

title

Methotrexate use in psoriasis and psoriatic arthritis (English)

1 reference

5 October 2017

1 reference

Cuellar ML

1

1 reference

5 October 2017

Espinoza LR

series ordinal

2

1 reference

5 October 2017

publication date

1 November 1997

1 reference

Rheumatic Diseases Clinics of North America

5 October 2017

published in

1 reference

5 October 2017

volume

23

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

797-809

1 reference

The Structure and Synthesis of the Liver L. casei Factor

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

PUVA and methotrexate therapy of psoriasis: how closely do dermatology departments follow treatment guidelines?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

The efficacy of methotrexate in psoriasis--a review of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Treatment of psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

The value of a baseline liver biopsy prior to methotrexate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Treatment of psoriasis with folic acid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Short-term methotrexate administration by low-dose infusion--does it influence clearance of psoriasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate in childhood psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate induced liver disease in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Detection of hepatotoxicity associated with methotrexate therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

The treatment of severe psoriasis. A national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Aminopterin for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate and liver biopsies. Is it really necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate in psoriasis: revised guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Hepatotoxicity of methotrexate in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

The practical use of methotrexate in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate revisited: effects of long-term treatment in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Therapy of psoriasis 1975

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Liver biopsy versus ultrasound in methotrexate-treated psoriasis: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Evaluation of Possible Chronic Hepatotoxicity From Methotrexate for Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate and histologic hepatic abnormalities: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970361-6

7 January 2021

10.1016/S0889-857X(05)70361-6

Identifiers

DOI

1 reference

5 October 2017

1 reference